PMV Pharmaceuticals, Inc. (PMVP)
NASDAQ: PMVP · Real-Time Price · USD
1.605
+0.035 (2.23%)
Nov 21, 2024, 12:44 PM EST - Market open

PMV Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018
Selling, General & Admin
21.0424.2525.0521.811.015.88
Upgrade
Research & Development
57.5555.8951.9936.4923.9320.76
Upgrade
Operating Expenses
78.5980.1377.0458.2934.9426.64
Upgrade
Operating Income
-78.59-80.13-77.04-58.29-34.94-26.64
Upgrade
Interest & Investment Income
11.5311.173.630.450.651.3
Upgrade
Other Non Operating Income (Expenses)
0.0800.090.02-0.14-0.01
Upgrade
Pretax Income
-67.57-68.96-73.33-57.82-34.43-25.34
Upgrade
Income Tax Expense
-16.10-0.010.020.010.01
Upgrade
Net Income
-51.47-68.96-73.32-57.85-34.44-25.35
Upgrade
Net Income to Common
-51.47-68.96-73.32-57.85-34.44-25.35
Upgrade
Shares Outstanding (Basic)
51484645143
Upgrade
Shares Outstanding (Diluted)
51484645143
Upgrade
Shares Change (YoY)
10.47%5.31%1.01%214.23%373.26%0.76%
Upgrade
EPS (Basic)
-1.00-1.44-1.61-1.28-2.40-8.35
Upgrade
EPS (Diluted)
-1.00-1.44-1.61-1.28-2.40-8.35
Upgrade
Free Cash Flow
-47.5-56.62-71.74-47.92-32.89-22.17
Upgrade
Free Cash Flow Per Share
-0.92-1.18-1.57-1.06-2.29-7.31
Upgrade
EBITDA
-77.12-78.88-76.73-57.99-34.62-26.25
Upgrade
D&A For EBITDA
1.461.260.320.310.320.39
Upgrade
EBIT
-78.59-80.13-77.04-58.29-34.94-26.64
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.